Skip the main content if you do not want to read it as the next section.
Skip the location trail if you do not want to read it as the next section.
Location trail
HEALTH PROFESSIONALS > TREATMENT GUIDELINES > CANCER TREATMENTS > BONE MARROW AND STEM CELL TREATMENTSUK Treatment Guidelines - Bone Marrow and Stem Cell Treatments
- Guideline for the flow cytometric enumeration of CD34+ haematopoietic stem cells – BCSH - 1999
- Guidance notes on the processing, storage and issue of bone marrow and blood stem cells - NHS Department of Health Expert Advisory Group - 1997
- Guidelines for the collection, processing and storage of human bone marrow and peripheral blood stem cells for transplantation - BCSH - 1994
Guideline for the flow cytometric enumeration of CD34+ haematopoietic stem cells – BCSH - 1999
Produced by: The British Committee for Standards in Haematology (BCSH) is a sub-committee of the British Society for Haematology (BSH).
Purpose: To provide haematologists with up to date advice on the diagnosis and treatment of haematological disease by the production of evidence based guidelines.
Can be obtained from: Clinical and Laboratory Haematology 1999; v21: p301-308 or British Society for Haematology, 100 White Lion Street, London N1 9PF Tel: 020 8643 7305
Guidance notes on the processing, storage and issue of bone marrow and blood stem cells - NHS Department of Health Expert Advisory Group - 1997
Produced by: NHS - Department of Health Expert Advisory Group 1997
Purpose: To provide guidance on the processing, storage and issue of bone marrow and blood stem cells.
Can be obtained from: NHS Responseline: 0870 1555 455. Ref: HSG(97)19. Further copies of this document are available from: Department of Health, PO Box 410, Wetherby LS23 7LL
Guidelines for the collection, processing and storage of human bone marrow and peripheral blood stem cells for transplantation - BCSH - 1994
Produced by: British Committee for Standards in Haematology, 1994
Purpose: Guidelines to cover the production, processing and storage of haemopoietic cells such as to allow their engraftment following myeloablative therapy.
Can be obtained from: Transfusion Medicine 1994; v4, p165-172.
Content last reviewed: 01 January 2002
Page last modified: 14 January 2009
Page last modified: 14 January 2009
